3084713-47-0
3084713-47-0
Chemical Structure
GLP-1R agonist 38
- CAS No.: 3084713-47-0
- Formula:C50H50F2N10O5
- Molecular Weight:908.99
InChIKey: LBXQDPNEKLTFCA-MZXNQBJUSA-N
SMILES: CC1=CC(N2N=C(C3(CC3)CN(C(C4=CC5=C(C=CC([C@H]6CCOC(C)(C)C6)=C5)N4[C@@]7(C8=NOC(N8)=O)C[C@@H]7C)=O)[C@H]9C)C9=C2N%10C=CN(C%11=C(F)C(C=NN%12C)=C%12C=C%11)C%10=O)=CC(C)=C1F
Biological Activity: GLP-1R agonist 38 (page 15, compound 1) is a glucagon-like peptide-1 receptor (GLP-1R) agonist. GLP-1R agonist 38 can be used for the study of metabolic disorders and related diseases, including but not limited to type II diabetes mellitus (T2DM), obesity and non-alcoholic fatty liver disease (NASH)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
GLP-1R agonist 38 | GLP-1R agonist 38 (page 15, compound 1) is a glucagon-like peptide-1 receptor (GLP-1R) agonist. GLP-1R agonist 38 can be used for the study of metabolic disorders and related diseases, including but not limited to type II diabetes mellitus (T2DM), obesity and non-alcoholic fatty liver disease (NASH). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
